Gensight Biologics SA GSGTF
$0.09
Last Updated: Aug 14, 12:00 AM·OOTC
Pricing for US stocks is delayed by 24 hours
GSGTF Shariah Compliance
Screening Methodology: AAOIFI
As of August 2026, Gensight Biologics SA is classified as halal.
HALAL
Report Source: undefined Quarter Report
Gensight Biologics SA. Stock Analysis GSGTF
United States Health Care Nano Cap GenSight Biologics SA is a clinical-stage gene therapy company, which engages in research and development of novel therapies for mitochondrial and neurodegenerative diseases of the eye. The company employs 13 full-time employees The company went IPO on 2016-07-13. The firm develops and commercializes gene therapy-based treatments of retinal degenerative diseases. The company develops approaches to prevent retinal degeneration in selected pathological conditions and to restore vision in patients suffering from low vision or blindness. The firm intends notably to develop a gene replacement therapy for Leber's hereditary optic neuropathy (LHON) and an optogenetic therapy for retinitis pigmentosa (RP).
Gensight Biologics SA (GSGTF) Chart
Financial Metrics & Statements of Gensight Biologics SA (GSGTF)
FAQ's for Gensight Biologics SA (GSGTF)
- As of August 2026, Gensight Biologics SA GSGTF is classified as halal according to Musaffa’s Shariah screening methodology. This classification is based on an assessment of the company’s business activities and financial ratios against Islamic investment guidelines.
- A stock is Shariah-compliant if the company operates in permissible business activities and meets Islamic financial screening thresholds. Musaffa analyzes Gensight Biologics SA using these criteria to determine its compliance status.
- Muslim investors may consider investing in Gensight Biologics SA if it meets Shariah compliance standards. Investors typically review the company’s business activities, debt levels, and non-permissible income before making a decision.
- Musaffa determines the Shariah status of Gensight Biologics SA by analyzing whether the company’s core business operations are permissible and whether its financial ratios fall within accepted Islamic thresholds.
- The Shariah compliance status of Gensight Biologics SA may be updated periodically when new financial statements, earnings reports, or business activity information become available.
- Yes. A stock that is currently Shariah-compliant may become non-compliant if the company’s financial ratios exceed Shariah thresholds or its business activities change.
- You can check the latest Shariah compliance status of Gensight Biologics SA on Musaffa’s stock page, where screening results and key financial indicators are updated to help Muslim investors make informed decisions.
Related Halal Stocks to Gensight Biologics SA (GSGTF)
Related Halal Stocks are Shariah-compliant companies that align with Islamic investment principles, avoiding prohibited industries like alcohol, gambling, and interest-based finance.
